87 related articles for article (PubMed ID: 29715087)
1. Tumor Cell-selective Synergism of TRAIL- and ATRA-induced Cytotoxicity in Breast Cancer Cells.
Reinhardt A; Liu H; Ma Y; Zhou Y; Zang C; Habbel JP; Possinger K; Eucker J
Anticancer Res; 2018 May; 38(5):2669-2682. PubMed ID: 29715087
[TBL] [Abstract][Full Text] [Related]
2. Loss of MCL1 function sensitizes the MDA-MB-231 breast cancer cells to rh-TRAIL by increasing DR4 levels.
De Blasio A; Pratelli G; Drago-Ferrante R; Saliba C; Baldacchino S; Grech G; Tesoriere G; Scerri C; Vento R; Di Fiore R
J Cell Physiol; 2019 Aug; 234(10):18432-18447. PubMed ID: 30912136
[TBL] [Abstract][Full Text] [Related]
3. Anti-tumor Effects of IL-1β Induced TRAIL-Expressing hUCMSCs on Embelin Treated Breast Cancer Cell Lines.
Teng JW; Hung E; Wu JM; Liang YH; Chiu YH; Tyan YS; Wang HS
Asian Pac J Cancer Prev; 2023 Apr; 24(4):1297-1305. PubMed ID: 37116152
[TBL] [Abstract][Full Text] [Related]
4. Enzymatically active cathepsin D sensitizes breast carcinoma cells to TRAIL.
Jancekova B; Ondrouskova E; Knopfova L; Smarda J; Benes P
Tumour Biol; 2016 Aug; 37(8):10685-96. PubMed ID: 26867770
[TBL] [Abstract][Full Text] [Related]
5. Activated human mesenchymal stem/stromal cells suppress metastatic features of MDA-MB-231 cells by secreting IFN-β.
Yoon N; Park MS; Shigemoto T; Peltier G; Lee RH
Cell Death Dis; 2016 Apr; 7(4):e2191. PubMed ID: 27077807
[TBL] [Abstract][Full Text] [Related]
6. Phenethyl isothiocyanate enhances TRAIL-induced apoptosis in oral cancer cells and xenografts.
Yeh CC; Ko HH; Hsieh YP; Wu KJ; Kuo MY; Deng YT
Clin Oral Investig; 2016 Dec; 20(9):2343-2352. PubMed ID: 26822174
[TBL] [Abstract][Full Text] [Related]
7. Novel targets for sensitizing breast cancer cells to TRAIL-induced apoptosis with siRNA delivery.
Thapa B; Bahadur Kc R; Uludağ H
Int J Cancer; 2018 Feb; 142(3):597-606. PubMed ID: 28960310
[TBL] [Abstract][Full Text] [Related]
8. Trailing TRAIL Resistance in Human Breast Adenocarcinoma Cells with Trichostatin A and Zebularine.
Wong SHM; Fang CM; Loh HS; Ngai SC
Anticancer Agents Med Chem; 2023; 23(7):817-831. PubMed ID: 36380402
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA induces TRAIL sensitization of human lung cancer cells through selective ER stress induction.
Kim EO; Kang SE; Im CR; Lee JH; Ahn KS; Yang WM; Um JY; Lee SG; Yun M
Int J Oncol; 2016 May; 48(5):2205-12. PubMed ID: 26983803
[TBL] [Abstract][Full Text] [Related]
10. Pro-apoptotic signaling induced by Retinoic acid and dsRNA is under the control of Interferon Regulatory Factor-3 in breast cancer cells.
Bernardo AR; Cosgaya JM; Aranda A; Jiménez-Lara AM
Apoptosis; 2017 Jul; 22(7):920-932. PubMed ID: 28409399
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic levels of cFLIP determine a broad susceptibility of breast cancer stem/progenitor-like cells to TRAIL.
French R; Hayward O; Jones S; Yang W; Clarkson R
Mol Cancer; 2015 Dec; 14():209. PubMed ID: 26667821
[TBL] [Abstract][Full Text] [Related]
12. β-catenin is regulated by USP9x and mediates resistance to TRAIL-induced apoptosis in breast cancer.
Ouyang W; Zhang S; Yang B; Yang C; Zhang J; Zhou F; Xie C
Oncol Rep; 2016 Feb; 35(2):717-24. PubMed ID: 26717875
[TBL] [Abstract][Full Text] [Related]
13. All-trans-retinoic acid modulates glycolysis via H19 and telomerase: the role of mir-let-7a in estrogen receptor-positive breast cancer cells.
El Habre R; Aoun R; Tahtouh R; Hilal G
BMC Cancer; 2024 May; 24(1):615. PubMed ID: 38773429
[TBL] [Abstract][Full Text] [Related]
14. ω-3 free fatty acids and all-trans retinoic acid synergistically induce growth inhibition of three subtypes of breast cancer cell lines.
Lin G; Zhu S; Wu Y; Song C; Wang W; Zhang Y; Chen YL; He Z
Sci Rep; 2017 Jun; 7(1):2929. PubMed ID: 28592877
[TBL] [Abstract][Full Text] [Related]
15. ELF3 plays an important role in defining TRAIL sensitivity in breast cancer by modulating the expression of decoy receptor 2 (DCR2).
Ghosal N; Tapadar P; Biswas D; Pal R
Mol Biol Rep; 2024 May; 51(1):671. PubMed ID: 38787503
[TBL] [Abstract][Full Text] [Related]
16. Enhanced expression of death receptor 5 is responsible for increased cytotoxicity of theophylline in combination with recombinant human TRAIL in MDA-MB-231 breast cancer cells.
Tapadar P; Pal A; Dutta S; Pal R
J Cancer Res Ther; 2022; 18(3):754-759. PubMed ID: 35900550
[TBL] [Abstract][Full Text] [Related]
17. The Novel, Orally Bioavailable CDK9 Inhibitor Atuveciclib Sensitises Pancreatic Cancer Cells to TRAIL-induced Cell Death.
Ruff JP; Kretz AL; Kornmann M; Henne-Bruns D; Lemke J; Traub B
Anticancer Res; 2021 Dec; 41(12):5973-5985. PubMed ID: 34848451
[TBL] [Abstract][Full Text] [Related]
18. GSK-126 Enhances All-Trans-Retinoic Acid (ATRA) Response in Hepatocellular Carcinoma (HCC) by Upregulating
Liu Z; Zheng Y
Discov Med; 2024 May; 36(184):1041-1053. PubMed ID: 38798263
[TBL] [Abstract][Full Text] [Related]
19. TRAIL Triggers CRAC-Dependent Calcium Influx and Apoptosis through the Recruitment of Autophagy Proteins to Death-Inducing Signaling Complex.
Airiau K; Vacher P; Micheau O; Prouzet-Mauleon V; Kroemer G; Moosavi MA; Djavaheri-Mergny M
Cells; 2021 Dec; 11(1):. PubMed ID: 35011619
[TBL] [Abstract][Full Text] [Related]
20. Profiling of the transcriptional response to all-trans retinoic acid in breast cancer cells reveals RARE-independent mechanisms of gene expression.
Coyle KM; Maxwell S; Thomas ML; Marcato P
Sci Rep; 2017 Nov; 7(1):16684. PubMed ID: 29192143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
